.OncoC4 is taking AcroImmune-- as well as its own in-house medical manufacturing capacities-- under ...
.Amgen has shared (PDF) the 1st period 3 records on its own $400 million dermatitis medicine, linkin...
.Biogen and UCB's rely on advancing in to period 3 on the back of an unsuccessful study looks to hav...
.Italian biotech Aptadir Rehabs has released along with the guarantee that its pipeline of preclinic...
.Wave Life Sciences has satisfied its objective in a Duchenne muscular dystrophy (DMD) study, placin...
.After a handful of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma layer, using...
.Achilles Therapeutics has destroyed its approach. The British biotech is actually quiting working o...
.Aligos Therapeutics is actually declaring a midstage succeed in metabolic-dysfunction affiliated st...
.Basilea Pharmaceutica's work developing brand new antifungals has received a notable boost coming f...
.Having currently gathered up the united state legal rights to Capricor Therapeutics' late-stage Duc...